Renovaro (FRA:2Q5) Treasury Stock : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Renovaro Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Renovaro's treasury stock for the quarter that ended in Sep. 2024 was €0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Renovaro Treasury Stock Historical Data

The historical data trend for Renovaro's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Treasury Stock Chart

Renovaro Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Treasury Stock

Get a 7-Day Free Trial

Renovaro Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Renovaro Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Renovaro Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

RENB:USA

Address

2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067

Website

https://www.renovarogroup.com

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Renovaro Headlines

No Headlines